Enhanced treatment, surveillance needed for certain melanoma patients to prevent secondary cancers
Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy ...
Aug 14, 2013
0
0